ASCT Viewpoint
Sep. 24, 2014

Study finds few physicians are recommending HPV vaccination for boys
Infection Control Today
Research from Moffitt Cancer Center shows family physicians and pediatricians are not always recommending vaccination against human papillomavirus for young male patients. Approximately 6 million people are newly infected with HPV each year, a virus that can lead to the development of cancer. There are also more than 600,000 new cases of cancer attributed to HPV each year worldwide.More

Announcing the Bob Gay Scholarship
The American Society for Cytotechnology (ASCT) is pleased to announce the creation of a new academic scholarship for cytotechnology students. The name of the scholarship is the Bob Gay Scholarship. It was created in honor and memory of Robert "Bob" Gay, who was a long-time supporter and founding member of the ASCT. For more than 30 years, Bob Gay made significant contributions to the field of cytotechnology through his work as a cytology supervisor, education coordinator and program director for several cytotechnology programs. He was dedicated in his support and advocacy for the field of cytology.More

Urine-based HPV test 'feasible alternative for cervical cancer screening'
Medical News Today
A new study published in The BMJ claims that a simple urine test for human papillomavirus — the main cause of cervical cancer — could increase screening uptake among women by offering them a non-invasive option.More

HPV vaccine reduces prevalence of targeted and non-targeted HPV types
Medical Xpress
A human papillomavirus vaccine used in Australia has reduced the prevalence of vaccine-targeted and non-targeted HPV types, researchers have found. The vaccine was designed to protect against four types of HPV, including two types that commonly cause genital warts and two that cause the majority of cervical cancers. More

Drinking alcohol may cause HPV infections to linger
Yahoo Health
Until now, the reasons some HPV infections linger has been a mystery, but recent research is beginning to shed light on possible causes: A new study, published in the journal Epidemiology & Infection, suggests that women who drink alcohol may have an increased risk of persistent HPV. When the National Cancer Center, Korea, scientists tested 9,230 women for HPV and asked them about their alcohol intake, they found that current drinkers were nearly three times more likely than non-drinkers to test positive for HPV at the beginning of the study, and then again at a two-year follow-up. More

Parental, adolescent knowledge of HPV unrelated to vaccination status
Recent data show parental and adolescent knowledge of HPV and HPV vaccination was not associated with adolescent vaccination among a predominantly low-income, black cohort. Jessica Fishman, Ph.D., of the University of Pennsylvania, and colleagues administered 18-item questionnaires to 211 adolescents and 149 parents to determine their knowledge of HPV and HPV vaccination at baseline. More

Many throat cancer patients can skip neck surgery
Medical Xpress
A new study shows that patients with human papillomavirus — the same virus associated with both cervical and head and neck cancer — positive oropharyngeal cancer see significantly higher rates of complete response on a post-radiation neck dissection than those with HPV-negative oropharyngeal cancer. More

Next-generation sequencing pinpoints multiple mutations
A typical cytology specimen contains sufficient DNA for next-generation sequencing, report researchers who suggest the tiny tissue samples should be routinely tested. Cytology specimens, such as fine-needle aspiration samples, commonly used for diagnosing primary and metastatic cancers, are typically tested for one biomarker at a time, lead investigator Christopher Hartley, M.D., from Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, explained to Medscape Medical News.More

Study: Age, medications play role in post-transplant cancer rate
By Karen Zabel
Organ transplant recipients regularly receive immunosuppressive drugs to help minimize the risk of rejection, but those drugs come with significant risks of their own, including leaving patients open to predatory infections and even certain types of cancer. Now, a new study suggests the type of immunosuppressant drug used as well as other factors may help predict those risks and possibly reduce them. The study was presented at the 2014 World Transplant Congress in San Francisco.More